Skip to main content
Friday
October 10, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
OCTOBER 10, 2025
GSK
GSK
GSK licenses companies to make cheap copies of HIV prevention drug
Unilever CEO set to leave after GSK debacle, arrival of activist investor
Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
Unilever's offer for GSK's consumer health raises doubts, questions over strategy
Unilever says it wants to buy GSK's consumer goods arm
New data shows GSK-Vir drug works against all Omicron mutations
UK approves GSK Covid drug, appears effective against Omicron
GSK says tests show antibody drug works against Omicron
GSK to develop longer-acting therapy for HIV with Japan's Shionogi
Study confirms GSK-Vir antibody drug reduces hospitalisation, death in Covid-19 patients
GSK fires former US govt vaccine head Slaoui over harassment allegation
GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine
GSK, Vir Biotech to expand Covid -19 research partnership for other diseases
Show More